Wells Fargo Maintains Overweight on Scotts Miracle Gro, Raises Price Target to $77
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and raises the price target from $74 to $77.
Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and raises the price target from $74 to $77.